Tumor-infiltrating CD8 + T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited-stage small cell esophageal carcinoma.

Authors :: Zhang Z
Zhang C
Zhang G
Luo Y
Xue L
Zeng Q
Wu P
Wang L
Sun N
He J
Source :: Clinical and translational medicine [Clin Transl Med] 2021 Jun; Vol. 11 (6), pp. e456.
Publication Year :: 2021

Subjects :: Carcinoma, Small Cell drug therapy
Carcinoma, Small Cell immunology
Esophageal Neoplasms drug therapy
Esophageal Neoplasms immunology
Follow-Up Studies
Humans
Prognosis
Retrospective Studies
Survival Rate
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Biomarkers, Tumor immunology
CD8-Positive T-Lymphocytes immunology
Carcinoma, Small Cell pathology
Chemotherapy, Adjuvant mortality
Esophageal Neoplasms pathology

Full Text Access

Tools